Inhibition of emetic effect of metformin with 5-ht3 receptor...

Details Inhibition of emetic effect of metformin with 5-ht3 receptor... Inhibition of emetic effect of metformin with 5-ht3 receptor...

A - Human Necessities

61

K

A61K 31/46 (2006.01) A61K 31/155 (2006.01) A61K 31/4178 (2006.01) A61K 31/439 (2006.01) A61K 45/06 (2006.01) A61P 1/08 (2006.01)

Patent

CA 2422711

Metformin is formulated as a pharmaceutical composition that also includes a 5- hydroxytryptamine-3 receptor antagonist to suppress the gastrointestinal side effects that are associated with metformin administration in many patients.

La metformine est formulée comme une composition pharmaceutique contenant aussi un antagoniste du récepteur 5-hydroxytryptamine-3 afin de supprimer les effets secondaires gastro-intestinaux qui sont associés à l'administration de la metformine chez de nombreux patients.

Affiliated with

Also associated with

Rating

Inhibition of emetic effect of metformin with 5-ht3 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of emetic effect of metformin with 5-ht3 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of emetic effect of metformin with 5-ht3 receptor... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2032989